| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |